IL-15 Primes a Highly Potent Anti-Leukemia Response By CD56bright NK Cells

被引:5
|
作者
Romee, Rizwan
Leone, Jeffrey W.
Schneider, Stephanie E.
Sullivan, Ryan P.
Fehniger, Todd A.
机构
关键词
D O I
10.1182/blood.V122.21.2283.2283
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2283
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells
    Wendt, Katy
    Wilk, Esther
    Buyny, Sabine
    Buer, Jan
    Schmidt, Reinhold E.
    Jacobs, Roland
    JOURNAL OF LEUKOCYTE BIOLOGY, 2006, 80 (06) : 1529 - 1541
  • [32] Characterization of CD56bright NK cells which inversely correlate with survival of melanoma patients
    de Jonge, Kaat
    Ebering, Anna
    Nassiri, Sina
    Baumgartner, Petra
    Speiser, Daniel E.
    SWISS MEDICAL WEEKLY, 2018, 148 : 39S - 40S
  • [33] Transcriptional signature of CD56bright NK cells predicts favourable prognosis in bladder cancer
    Khan, Md Abdullah Al Kamran
    Sedgwick, Alexander James
    Sun, Yuhan
    Vivian, Julian P.
    Corbett, Alexandra J.
    Dolcetti, Riccardo
    Mantamadiotis, Theo
    Mangiola, Stefano
    Barrow, Alexander David
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [34] An IL-2 Paradox: Blocking CD25 on T Cells Induces IL-2-Driven Activation of CD56bright NK Cells
    Martin, Jayne F.
    Perry, Justin S. A.
    Jakhete, Neha R.
    Wang, Xiang
    Bielekova, Bibiana
    JOURNAL OF IMMUNOLOGY, 2010, 185 (02): : 1311 - 1320
  • [35] An IL-2 Paradox; Blocking CD25 on T Cells Induces IL-2-Driven Activation of CD56bright NK Cells
    Martin, Jayne F.
    Jakhete, Neha R.
    Wang, Xiang
    Bielekova, Bibiana
    NEUROLOGY, 2010, 74 (09) : A368 - A368
  • [36] Characterization of CD56bright NK cells in Daclizumab HYP-treated RRMS patients
    Huss, David J.
    Fragoso, Maria F.
    Cullen, Patrick
    Allaire, Norm
    Fontenot, Jason D.
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 275 (1-2) : 86 - 86
  • [37] THE CD56BRIGHT SUBSET OF NK CELLS IS GREATLY EXPANDED IN INFLAMMATORY SYNOVIAL FLUID AND TISSUE
    Dalbeth, N.
    Callan, M.
    RHEUMATOLOGY, 2003, 42 : 126 - 126
  • [38] Highly activated TRAIL+ CD56bright NK cells are associated with the liver damage in HBV-LC patients
    Jiang, Yujie
    Qin, Shuang
    Wei, Xin
    Liu, Xiaoyuan
    Guan, Jingjing
    Zhu, Hengyue
    Chang, Guolin
    Chen, Yingxiao
    Lu, Hong
    Qian, Jingjing
    Wang, Zhongyong
    Shen, Mo
    Lin, Xiangyang
    IMMUNOLOGY LETTERS, 2021, 232 : 9 - 19
  • [39] Recombinant Human IL-12 Exerts Differential Effects on Circulating CD56bright and CD56dim NK Cells in Healthy Human Subjects
    Thomas, Simmy
    Lawrence, Chris E.
    Mar, Vernon
    Kha, Hue
    Basile, Lena A.
    BLOOD, 2014, 124 (21)
  • [40] IL-8 inhibits susceptibility of CD56bright CD16negative NK cells against primary human hepatic stellate cells
    Langhans, Bettina
    Alwan, Abdel Wahed
    Althausen, Eva Maria
    Kraemer, Benjamin
    Glaessner, Andreas
    Nattermann, Jacob
    Strassburg, Christian P.
    Spengler, Ulrich
    HEPATOLOGY, 2013, 58 : 1188A - 1188A